Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)

NCT02955810 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Daratumumab
DRUG: Cyclophosphamide
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

National University of Ireland, Galway, Ireland

Collaborators

[object Object]
[object Object]